Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Harvey Wong"'
Publikováno v:
Drugs in R&D, Vol 24, Iss 2, Pp 155-167 (2024)
Abstract Background and Objectives Despite significant progress in biomedical research, the rate of success in oncology drug development remains inferior to that of other therapeutic fields. Mechanistic models provide comprehensive understanding of t
Externí odkaz:
https://doaj.org/article/edd67a37d356415091a99db705d813f0
Autor:
Anne-Sophie Rebstock, Mareike Wiedmann, Beatrix Stelte-Ludwig, Harvey Wong, Amy J. Johnson, Raquel Izumi, Ahmed Hamdy, Hans-Georg Lerchen
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: The development of bioconjugates for the targeted delivery of anticancer agents is gaining momentum after recent success of antibody drug conjugates (ADCs) in the clinic. Smaller format conjugates may have several advantages including b
Externí odkaz:
https://doaj.org/article/48196de27ca84870b273d09b3f4c3f6d
Autor:
Jeffrey R. Proctor, Harvey Wong
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Exposure–response (ER) analysis is used to optimize dose and dose regimens during clinical development. Characterization of relationships between drug exposure and efficacy or safety outcomes can be utilized to make dose adjustments that i
Externí odkaz:
https://doaj.org/article/6501a33ae1d948689a848346cb263532
Autor:
Richard Zang, Aline Barth, Harvey Wong, Jan Marik, Jie Shen, Julie Lade, Kerri Grove, Matthew R. Durk, Neil Parrott, Patrick J. Rudewicz, Sylvia Zhao, Tao Wang, Zhengyin Yan, Donglu Zhang
Publikováno v:
Journal of Medicinal Chemistry. 65:8713-8734
The "free drug hypothesis" assumes that, in the absence of transporters, the steady state free plasma concentrations equal to that at the site of action that elicit pharmacologic effects. While it is important to utilize the free drug hypothesis, exc
Publikováno v:
Drug Metabolism and Disposition. 50:1170-1181
Predicting human pharmacokinetics (PK) during the drug discovery phase is valuable to assess doses required to reach therapeutic exposures. For orally administered compounds, however, this can be especially difficult, since the absorption process is
Autor:
Stephen E. Gould, Frederic J. de Sauvage, Robert L. Yauch, Tom Januario, Hank La, Patricia Pacheco, Kristina A. West, Bruno Alicke, Harvey Wong
PDF file - 64K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a94d3e334ec0722a175a9109310ce0
https://doi.org/10.1158/1078-0432.22442118
https://doi.org/10.1158/1078-0432.22442118
Autor:
John Prescott, Marcia Belvin, Sanh Tan Lam, Ron Aoyama, Blake T. Aftab, Yongchang Shi, Klaus P. Hoeflich, Edna F. Choo, Geoffrey Del Rosario, Congfen Li, Peiwen Yu, Jean-Francois Martini, Lillian Lee, Joseph A. Ware, Amy Peterson, Laurent Vernillet, Harvey Wong
PDF file, 66KB, Plot of observed versus predicted GDC-0973 plasma concentrations following fitting of PK model (Figure 1A) to mean GDC-0973 plasma concentration-time data from patients in cohort 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be78dc48256c8cf14c7446f9f4f9582f
https://doi.org/10.1158/1078-0432.22445543
https://doi.org/10.1158/1078-0432.22445543
Autor:
Victor Moreno, Harvey Wong, Raquel Izumi, Xin Huang, Ahmed M. Hamdy, Joy M. Greer, Melanie M. Frigault, Oliver Boix, Claudia Merz, Isabelle Genvresse, Ray Valencia, Daniel Morillo, Raul Cordoba, Grzegorz Nowakowski, Emerson Lim, Valentina Boni, Jennifer R. Diamond
Supplementary Table from First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::349103a7690abd8eb9a33fa70122d36c
https://doi.org/10.1158/1078-0432.22488152
https://doi.org/10.1158/1078-0432.22488152
Autor:
Stephen E. Gould, Cornelis E.C.A. Hop, Lori S. Friedman, Jay Tibbitts, Frank-Peter Theil, Erin McNamara, Hank La, Xiao Ding, Bruno Alicke, Edna F. Choo, Harvey Wong
PDF file, 91KB, Population Pharmacodynamic Parameter Estimates for Anti-Cancer Agents.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f81c2c04343c4e4155724e9ae9a38ba
https://doi.org/10.1158/1078-0432.22446335
https://doi.org/10.1158/1078-0432.22446335
Autor:
John Prescott, Marcia Belvin, Sanh Tan Lam, Ron Aoyama, Blake T. Aftab, Yongchang Shi, Klaus P. Hoeflich, Edna F. Choo, Geoffrey Del Rosario, Congfen Li, Peiwen Yu, Jean-Francois Martini, Lillian Lee, Joseph A. Ware, Amy Peterson, Laurent Vernillet, Harvey Wong
PDF file, 57KB, Structure of GDC-0973.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e24f522dbb0b50d80f365a3ee1b197
https://doi.org/10.1158/1078-0432.22445549
https://doi.org/10.1158/1078-0432.22445549